Yolanda Guerra Mendoza

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Venues

Drug safety

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yolanda Guerra Mendoza, Viviane Jusot, Félix Adou, Martin O C Ota, Diego Mpia Elenge, Tasim Begum, Nkululeko Mdladla, Olga Menang, Jean Claude Yavo, Mamadou Kamagaté
Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK's Training and Mentoring Pilot Project in the Abidjan Region. Drug safety (2023)
Viviane Jusot, Frider Chimimba, Nettie Dzabala, Olga Menang, Joy Cole, Gregory Gardiner, Opokua Ofori-Anyinam, Olakunle Oladehin, Cecilia Sambakunsi, Mphatso Kawaye, Jens-Ulrich Stegmann, Yolanda Guerra Mendoza
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi. Drug safety 43 (6) (2021)
Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach, Marc Lievens, Opokua Ofori-Anyinam, Jean-Yves Pirçon, Jens-Ulrich Stegmann, Pascale Vandoolaeghe, Lucas Otieno, Walter Otieno, Seth Owusu-Agyei, Jahit Sacarlal, Nahya Salim Masoud, Hermann Sorgho, Marcel Tanner, Halidou Tinto, Innocent Valea, Ali Takadir Mtoro, Patricia Njuguna, Martina Oneko, Godfrey Allan Otieno, Kephas Otieno, Samwel Gesase, Mary J Hamel, Irving Hoffman, Seyram Kaali, Portia Kamthunzi, Peter Kremsner, Miguel Lanaspa, Bertrand Lell, John P A Lusingu, Anangisye Malabeja, Pedro Aide, Pauline Akoo, Daniel Ansong, Kwaku Poku Asante, James A Berkley, Samuel Adjei, Tsiri Agbenyega, Selidji Todagbe Agnandji, Lode Schuerman
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa. Human vaccines & immunotherapeutics 15 (10) (2019)

Yolanda Guerra Mendoza.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yolanda Guerra Mendoza